nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abstracts author index
|
|
|
2008 |
|
14 |
p. 152-153 2 p. |
artikel |
2 |
Accessi venosi centrali: Inquadramento E Idicazioni
|
Maiorino, L. |
|
2008 |
|
14 |
p. 148- 1 p. |
artikel |
3 |
Activity and tolerability of Cisplatin (CDDP) and Fotemustine (FTM) combination in the treatment of patients with non-small cell lung cancer (NSCLC) with brain metastases (BM): A multicentric phase II study of the Gruppo Oncologico dell’Italia Meridionale (GOIM)
|
Galetta, D. |
|
2008 |
|
14 |
p. 151- 1 p. |
artikel |
4 |
Acute non-lymphocytic leukemia: Onset after treatment for Hodgkin’s disease
|
Santoro, M. |
|
2008 |
|
14 |
p. 129-130 2 p. |
artikel |
5 |
Adjuvant chemotherapy of colon cancer current strategies
|
Barone, Carlo |
|
2008 |
|
14 |
p. 60-63 4 p. |
artikel |
6 |
A metronomic treatment with oral chemotherapy in patients elderly with metastatic breast cancer
|
Vitello, S. |
|
2008 |
|
14 |
p. 116-117 2 p. |
artikel |
7 |
Angiosarcoma of the right atrium: A case report
|
D’Addetta, C. |
|
2008 |
|
14 |
p. 145- 1 p. |
artikel |
8 |
Anxiety: A psychological observational study before mammography screening
|
Barni, S. |
|
2008 |
|
14 |
p. 147- 1 p. |
artikel |
9 |
Appropriateness of the use of PET/CT in the radiotherapy treatment planning for Hodgkin’s lymphoma
|
Santoro, M. |
|
2008 |
|
14 |
p. 118- 1 p. |
artikel |
10 |
Beta-erythropoietin in clinical practice: GOIM 2705 multicenter observational study
|
Addeo, Raffaele |
|
2008 |
|
14 |
p. 147- 1 p. |
artikel |
11 |
Bevacizumab+folfiri as first-line treatment in advanced colorectal cancer (ACC): A multicenter phase II study of the Gruppo Oncologico dell’ Italia Meridionale (prot. GOIM 2601)
|
Giuliani, F. |
|
2008 |
|
14 |
p. 121- 1 p. |
artikel |
12 |
Bi-weekly administration of capecitabine+oxaliplatin (XELOX-2) in first line treatment of advanced colorectal cancer (ACRC): Preliminary results
|
Di Bisceglie, M. |
|
2008 |
|
14 |
p. 120- 1 p. |
artikel |
13 |
Cetuximab induced cutaneous rash: Does it affect psychological well-being in colorectal cancer patients?
|
Romito, F. |
|
2008 |
|
14 |
p. 122- 1 p. |
artikel |
14 |
Chemo-hormonal therapy for metastatic breast cancer patients: Treatment strategy
|
Barni, S. |
|
2008 |
|
14 |
p. 13-20 8 p. |
artikel |
15 |
Chemo-radiotherapy in locally advanced rectal cancer: What is the optimal strategy?
|
Avallone, Antonio |
|
2008 |
|
14 |
p. 70-73 4 p. |
artikel |
16 |
Circulating tumour cells in colorectal cancer
|
Di Costanzo, Francesco |
|
2008 |
|
14 |
p. 52-59 8 p. |
artikel |
17 |
Clinical results of EGFR-targeted therapies in advanced colorectal cancer
|
Maiello, Evaristo |
|
2008 |
|
14 |
p. 64-69 6 p. |
artikel |
18 |
Contribution of the functional imaging in the radiotherapy treatment planning for malignant glioma: Revision of the literature
|
Santoro, M. |
|
2008 |
|
14 |
p. 137-138 2 p. |
artikel |
19 |
Controversies in adjuvant endocrine therapy for pre- and post-menopausal women with breast cancer
|
Ciccarese, Mariangela |
|
2008 |
|
14 |
p. 4-9 6 p. |
artikel |
20 |
Coping with cancer: A prospective psycho-social analysis of cancer patients and their non-medical caregivers (cg) – A goim study
|
Mistretta, G. |
|
2008 |
|
14 |
p. 141- 1 p. |
artikel |
21 |
Correlation between basal bilirubin levels and survival in advanced colorectal carcinoma treated with CPT-11-based chemotherapy: A study of the Gruppo Oncologico Italia Meridionale (G.O.I.M.)
|
Colucci, Giuseppe |
|
2008 |
|
14 |
p. 94-99 6 p. |
artikel |
22 |
Current challenges and future perspectives in the medical treatment of solid tumours
|
Sobrero, A. |
|
2008 |
|
14 |
p. 140- 1 p. |
artikel |
23 |
Current challenges and future perspectives in the medical treatment of solid tumours
|
Sobrero, A. |
|
2008 |
|
14 |
p. 91-93 3 p. |
artikel |
24 |
CYR61 down-modulation sensitizes prostate cancer cells to zoledronic acid and docetaxel: A new anti-cancer strategy
|
Caraglia, M. |
|
2008 |
|
14 |
p. 123-124 2 p. |
artikel |
25 |
Docetaxel and zoledronic acid combination administered in two different sequences in hormone refractory prostate cancer patients: Phase I clinical study – ZANTE
|
Facchini, G. |
|
2008 |
|
14 |
p. 124- 1 p. |
artikel |
26 |
DVD-based group information for cancer inpatients and families
|
Romito, F. |
|
2008 |
|
14 |
p. 148-149 2 p. |
artikel |
27 |
Editorial board
|
|
|
2008 |
|
14 |
p. ii- 1 p. |
artikel |
28 |
EGFR mutations in patients with non-small cell lung cancer (NSCLC) and correlation with sensitivity to erlotinib
|
Ricciardi, S. |
|
2008 |
|
14 |
p. 134- 1 p. |
artikel |
29 |
Electrochemotherapy (ECT) for the treatment of superficial tumour metastases
|
Guida, M. |
|
2008 |
|
14 |
p. 132- 1 p. |
artikel |
30 |
Epirubicin, taxotere and fluorouracil modulated by folinic acid in the treatment of advanced gastric cancer: A phase II study of the Gruppo Oncologico dell’ Italia Meridionale (GOIM)
|
Giuliani, F. |
|
2008 |
|
14 |
p. 107-112 6 p. |
artikel |
31 |
Evaluation of Folfox toxicity in a consecutive series of elderly cancer patients
|
Tambaro, R. |
|
2008 |
|
14 |
p. 128- 1 p. |
artikel |
32 |
Experience of 170 cases of ductal carcinoma in ‘ (DCIS)
|
D’Addetta, C. |
|
2008 |
|
14 |
p. 115- 1 p. |
artikel |
33 |
First-line cisplatin (P) with docetaxel (TXT) or vinorelbine (VNR) in patients with advanced non-small-cell lung cancer: A phase II randomized trial of Gruppo Oncologico Italia Meridionale
|
Gebbia, V. |
|
2008 |
|
14 |
p. 151- 1 p. |
artikel |
34 |
Folfiri versus xeliri in untreated advanced colorectal cancer: A phase II randomised trial of the Gruppo Oncologico dell’ Italia Meridionale (prot. GOIM 2405)
|
Giuliani, F. |
|
2008 |
|
14 |
p. 120-121 2 p. |
artikel |
35 |
Gastrointestinal stromal tumours: Two case reports
|
Camplese, P. |
|
2008 |
|
14 |
p. 119- 1 p. |
artikel |
36 |
High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: Long term survival data
|
Conti, F. |
|
2008 |
|
14 |
p. 115- 1 p. |
artikel |
37 |
High-dose chemotherapy as initial salvage treatment in relapsed testicular cancer patients
|
Morelli, F. |
|
2008 |
|
14 |
p. 124-125 2 p. |
artikel |
38 |
Image guided radiation therapy (IGRT) in the treatment planning of prostate cancer: Accuracy and precision of radiation therapy through modern imaging technologies
|
Santoro, M. |
|
2008 |
|
14 |
p. 125-126 2 p. |
artikel |
39 |
Imatinib in the treatment of dermatofibrosarcoma protuberans
|
Fattoruso, S.I.S. |
|
2008 |
|
14 |
p. 145- 1 p. |
artikel |
40 |
Improvement of pain and psychological status after six months of psychotherapy in cancer patients
|
Tulipani, C. |
|
2008 |
|
14 |
p. 148- 1 p. |
artikel |
41 |
Integrated regimen therapeutic (polybiologic-chemotherapy) for melanoma advanced
|
Vitello, S. |
|
2008 |
|
14 |
p. 135- 1 p. |
artikel |
42 |
Intravescical Gemcitabine versus Mitomycin for recurrent superficial bladder tumours (stages pTa and pT1): A randomized prospective study
|
Faiola, Vincenzo |
|
2008 |
|
14 |
p. 124- 1 p. |
artikel |
43 |
Is mammography screening anxiety related to personal coping style?
|
Bonetti, M.L. |
|
2008 |
|
14 |
p. 147-148 2 p. |
artikel |
44 |
Is oral metronomic cyclophosphamide (CTX) an effective palliative treatment for patients with metastatic breast carcinoma (ABC)? experience from a retrospective series of patients
|
Boussen, H. |
|
2008 |
|
14 |
p. 114- 1 p. |
artikel |
45 |
Laparoscopy in colon cancer: The new standard?
|
Fumo, F. |
|
2008 |
|
14 |
p. 100-101 2 p. |
artikel |
46 |
Making the right choice in the adjuvant chemotherapy of primary breast cancer
|
Lopez, Massimo |
|
2008 |
|
14 |
p. 10-12 3 p. |
artikel |
47 |
Malignant pleural mesothelioma: Scheme therapeutic after standard treatment (study of phase II)
|
Vitello, S. |
|
2008 |
|
14 |
p. 150- 1 p. |
artikel |
48 |
Management of toxicity in patients treated with tyrosine kinase inhibitors (TKI)
|
Naglieri, Emanuele |
|
2008 |
|
14 |
p. 42-45 4 p. |
artikel |
49 |
Merkel cell carcinoma
|
Viola, G. |
|
2008 |
|
14 |
p. 146- 1 p. |
artikel |
50 |
Metronomic oral Vinorelbine and Temozolomide, after whole brain radiotherapy, for the treatment of breast cancer patients with brain metastasis. A Phase II study
|
Montella, Liliana |
|
2008 |
|
14 |
p. 116- 1 p. |
artikel |
51 |
Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid
|
Marra, M. |
|
2008 |
|
14 |
p. 79-85 7 p. |
artikel |
52 |
Molecular biology of renal-cell carcinoma
|
De Luca, Antonella |
|
2008 |
|
14 |
p. 30-34 5 p. |
artikel |
53 |
Molecular predictive factors of response to anti-EGFR antibodies in colorectal cancer patients
|
Santini, Daniele |
|
2008 |
|
14 |
p. 86-90 5 p. |
artikel |
54 |
Nuovo ruolo degli inibitori dell’aromatasi: Impiego in terapia adiuvante
|
Molino, A. |
|
2008 |
|
14 |
p. 115-116 2 p. |
artikel |
55 |
Oligometastases: A new reality in the therapy of the cancer
|
Santoro, M. |
|
2008 |
|
14 |
p. 139- 1 p. |
artikel |
56 |
Optimization of the therapeutic index through the integration among target therapy and radiotherapy
|
Santoro, M. |
|
2008 |
|
14 |
p. 142-144 3 p. |
artikel |
57 |
Palonosetron for prevention of acute and delayed nausea and vomiting induced by moderately emetogenic adjuvant folfox-4 regimen in colorectal cancer (CRC) patients: A phase II study of the Gruppo Oncologico dell’ Italia Meridionale (GOIM)
|
Giuliani, F. |
|
2008 |
|
14 |
p. 102-106 5 p. |
artikel |
58 |
Peritonectomy and intraoperative chemohypertermia as treatment of peritoneal carcinosis: Our experience
|
Camplese, P. |
|
2008 |
|
14 |
p. 132-133 2 p. |
artikel |
59 |
Pharmacogenetics in oncology
|
Danesi, R. |
|
2008 |
|
14 |
p. 74-78 5 p. |
artikel |
60 |
Pharmacogenetics in oncology
|
Danesi, R. |
|
2008 |
|
14 |
p. 139- 1 p. |
artikel |
61 |
Prognostic and predictive factors of breast carcinoma: Beyond hormonal receptors and HER2
|
Nappi, Oscar |
|
2008 |
|
14 |
p. 1-3 3 p. |
artikel |
62 |
Prognostic factors in advanced renal cell cancer
|
Porta, Camillo |
|
2008 |
|
14 |
p. 35-37 3 p. |
artikel |
63 |
Radiochemotherapy for anal carcinoma: Our experience
|
Morelli, F. |
|
2008 |
|
14 |
p. 121-122 2 p. |
artikel |
64 |
Radiotherapy and temozolomide in glioblastoma: Predictive factors of response to the treatment
|
Santoro, M. |
|
2008 |
|
14 |
p. 136-137 2 p. |
artikel |
65 |
Rediscovering immunotherapy in combination with molecularly targeted agents in renal cell cancer
|
Procopio, G. |
|
2008 |
|
14 |
p. 125- 1 p. |
artikel |
66 |
Role of positron emission tomography (PET) in advanced stage non-small cell lung cancer patients treated with cisplatin-based doublets
|
Gebbia, V. |
|
2008 |
|
14 |
p. 150- 1 p. |
artikel |
67 |
Second-line chemotherapy in advanced cancer of the pancreas: A multicenter survey of the Gruppo Oncologico Italia Meridonale on the activity and safety of the folfiri regimen in clinical practice
|
Arcara, C. |
|
2008 |
|
14 |
p. 119- 1 p. |
artikel |
68 |
Second solid cancer after Hodgkin’s disease: Analysis of the risk and revision of the literature
|
Santoro, M. |
|
2008 |
|
14 |
p. 130-131 2 p. |
artikel |
69 |
Sorafenib plus long-acting octreotide in advanced hepatocellular carcinoma. Preliminary results of a multicenter ongoing study
|
Del Prete, S. |
|
2008 |
|
14 |
p. 119-120 2 p. |
artikel |
70 |
Sunitinib in advanced clear cell renal cancer: A single centre experience
|
Bruni, G.S. |
|
2008 |
|
14 |
p. 123- 1 p. |
artikel |
71 |
Tamoxifen in the treatment of recurrent, advanced border line ovarian cancer: A single centre experience
|
Pisano, C. |
|
2008 |
|
14 |
p. 125- 1 p. |
artikel |
72 |
Target therapy in metastatic renal cell carcinoma
|
Cartenì, G. |
|
2008 |
|
14 |
p. 38-41 4 p. |
artikel |
73 |
The burden of renal cell cancer: A retrospective longitudinal study on occurrence, outcomes and cost using an administrative claims database
|
Mantovani, Lorenzo G |
|
2008 |
|
14 |
p. 46-51 6 p. |
artikel |
74 |
The delay time in radiotherapy
|
Santoro, M. |
|
2008 |
|
14 |
p. 142- 1 p. |
artikel |
75 |
The role of bevacizumab in breast cancer
|
Daniele, Gennaro |
|
2008 |
|
14 |
p. 26-29 4 p. |
artikel |
76 |
Toward a new prognostic-therapeutic index in geriatric oncology
|
Bellavia, M. |
|
2008 |
|
14 |
p. 127-128 2 p. |
artikel |
77 |
Treatment in metastatic prostate cancer with hormone refractory
|
Vitello, S. |
|
2008 |
|
14 |
p. 1- 1 p. |
artikel |
78 |
Treatment of HER-2 positive breast cancer
|
Clavarezza, Matteo |
|
2008 |
|
14 |
p. 21-25 5 p. |
artikel |
79 |
Upfront aromatase inhibitors (AI) in early breast cancer: Against
|
Boccardo, F. |
|
2008 |
|
14 |
p. 113-114 2 p. |
artikel |